Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nicol

Showing results (341-350 of 350) with videos related to

Pageof 35
Sort By:
You have reached the last page of results.This site can display upto 350 results.
The Journal of Trauma and Acute Care Surgery|September 25, 2015
Indications for use of thoracic, abdominal, pelvic, and vascular damage control interventions in trauma patients: A content analysis and expert appropriateness rating studyDerek J Roberts, Niklas Bobrovitz, David A Zygun, et al.
Frontiers in Immunology|November 15, 2021
Macrophage Selenoproteins Restrict Intracellular Replication of <i>Francisella tularensis</i> and Are Essential for Host ImmunityRachel L Markley, Katherine H Restori, Bhuvana Katkere, et al.
Annals of Surgery|October 8, 2015
Indications for Use of Damage Control Surgery in Civilian Trauma Patients: A Content Analysis and Expert Appropriateness Rating StudyDerek J Roberts, Niklas Bobrovitz, David A Zygun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 1998
Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumorsM L Rothenberg, A Sharma, G R Weiss, et al.
Neuro-Oncology|September 8, 2011
Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcomaNicholas Butowski, Susan M Chang, Kathleen R Lamborn, et al.
Biorxiv : the Preprint Server for Biology|April 6, 2021
Combinatorial optimization of mRNA structure, stability, and translation for RNA-based therapeuticsKathrin Leppek, Gun Woo Byeon, Wipapat Kladwang, et al.
Nature Machine Intelligence|December 26, 2022
Deep learning models for predicting RNA degradation via dual crowdsourcingHannah K Wayment-Steele, Wipapat Kladwang, Andrew M Watkins, et al.
Arxiv|October 21, 2021
Deep learning models for predicting RNA degradation via dual crowdsourcingHannah K Wayment-Steele, Wipapat Kladwang, Andrew M Watkins, et al.
Nature Communications|March 23, 2022
Combinatorial optimization of mRNA structure, stability, and translation for RNA-based therapeuticsKathrin Leppek, Gun Woo Byeon, Wipapat Kladwang, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Ribonanza: deep learning of RNA structure through dual crowdsourcingShujun He, Rui Huang, Jill Townley, et al.
Pageof 35

Showing results (341-350 of 350) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 350 results.
The Journal of Trauma and Acute Care Surgery|September 25, 2015
Indications for use of thoracic, abdominal, pelvic, and vascular damage control interventions in trauma patients: A content analysis and expert appropriateness rating studyDerek J Roberts, Niklas Bobrovitz, David A Zygun, et al.
Frontiers in Immunology|November 15, 2021
Macrophage Selenoproteins Restrict Intracellular Replication of <i>Francisella tularensis</i> and Are Essential for Host ImmunityRachel L Markley, Katherine H Restori, Bhuvana Katkere, et al.
Annals of Surgery|October 8, 2015
Indications for Use of Damage Control Surgery in Civilian Trauma Patients: A Content Analysis and Expert Appropriateness Rating StudyDerek J Roberts, Niklas Bobrovitz, David A Zygun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 1998
Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumorsM L Rothenberg, A Sharma, G R Weiss, et al.
Neuro-Oncology|September 8, 2011
Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcomaNicholas Butowski, Susan M Chang, Kathleen R Lamborn, et al.
Biorxiv : the Preprint Server for Biology|April 6, 2021
Combinatorial optimization of mRNA structure, stability, and translation for RNA-based therapeuticsKathrin Leppek, Gun Woo Byeon, Wipapat Kladwang, et al.
Nature Machine Intelligence|December 26, 2022
Deep learning models for predicting RNA degradation via dual crowdsourcingHannah K Wayment-Steele, Wipapat Kladwang, Andrew M Watkins, et al.
Arxiv|October 21, 2021
Deep learning models for predicting RNA degradation via dual crowdsourcingHannah K Wayment-Steele, Wipapat Kladwang, Andrew M Watkins, et al.
Nature Communications|March 23, 2022
Combinatorial optimization of mRNA structure, stability, and translation for RNA-based therapeuticsKathrin Leppek, Gun Woo Byeon, Wipapat Kladwang, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Ribonanza: deep learning of RNA structure through dual crowdsourcingShujun He, Rui Huang, Jill Townley, et al.
Pageof 35